These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2754835)

  • 1. [The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy].
    Miyoshi H; Oshiba S; Matsumoto A; Hayashi K; Tei H
    Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):280. PubMed ID: 2754835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the usefulness of haptoglobin used on endoscopic injection sclerotherapy].
    Matsumoto A; Miyoshi H; Takada K; Hayashi K; Asada S; Hirata I; Ohshiba S
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1343-9. PubMed ID: 2214258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
    Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
    Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.
    Hashizume M; Kitano S; Yamaga H; Sugimachi K
    Lancet; 1988 Aug; 2(8606):340-1. PubMed ID: 2899760
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathological studies of esophageal wall after endoscopic injection sclerotherapy].
    Arakawa M; Kage M; Inoue R; Nagata K; Toyonaga A
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2359-64. PubMed ID: 3221489
    [No Abstract]   [Full Text] [Related]  

  • 6. Intramural hematoma of the esophagus--a complication of endoscopic injection sclerotherapy.
    Jones DB; Frost RA; Goodacre RL
    Gastrointest Endosc; 1986 Jun; 32(3):239-40. PubMed ID: 3487486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects on the heart and lung after endoscopic injection sclerotherapy for esophageal varices].
    Kumazawa K; Haga S; Kawata H; Azuhata H; Shimizu T; Mori M; Kikuchi T; Kajiwara T; Sakakibara N; Ichioka S
    Nihon Shokakibyo Gakkai Zasshi; 1985 Mar; 82(3):391-7. PubMed ID: 4010006
    [No Abstract]   [Full Text] [Related]  

  • 8. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
    Bellary SV; Isaacs P
    Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
    Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
    Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purulent pericarditis: a complication of endoscopic oesophageal variceal sclerotherapy.
    Gupta S; Thompson K; Grellier L
    Endoscopy; 2005 Jul; 37(7):688. PubMed ID: 16010625
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosquamous carcinoma of the esophagus after endoscopic variceal sclerotherapy: a case report and review of the literature.
    Sakata K; Ishida M; Hiraishi H; Sasai T; Watanabe N; Suzuki Y; Masuyama H; Terano A
    Gastrointest Endosc; 1998 Mar; 47(3):294-9. PubMed ID: 9540886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary circulatory disturbance following endoscopic injection sclerotherapy].
    Uchibori S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):833-9. PubMed ID: 8366622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
    Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
    Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of esophageal varices in children by injection sclerotherapy.
    Howard ER; Stamatakis JD; Mowat AP
    J Pediatr Surg; 1984 Feb; 19(1):2-5. PubMed ID: 6607986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
    Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
    Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient tricuspid regurgitation after endoscopic injection sclerotherapy for esophageal varices.
    Tanaka M; Miyoshi H; Matsumoto A; Hirata I; Ohshiba S; Yoneda Y
    Gastroenterol Jpn; 1989 Dec; 24(6):737. PubMed ID: 2606308
    [No Abstract]   [Full Text] [Related]  

  • 17. Injection sclerotherapy for bleeding varices--a review.
    Bhasin DK; Koshy A
    Indian J Gastroenterol; 1985 Jan; 4(1):35-7. PubMed ID: 3881343
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive bleeding from rectal varices following repeated injection sclerotherapy of oesophageal varices.
    Keane RM; Britton DC
    Br J Surg; 1986 Feb; 73(2):120. PubMed ID: 3484983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of elective endoscopic sclerotherapy of hemorrhage from esophageal varices. 2-year follow-up].
    Cabriada J; Orive V; Alzate LF; Arenas JI
    Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):429-34. PubMed ID: 3265215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.